Robert Connelly - CEO, President and Director, Director at Elicio Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, President and Director, Director
Stock Symbol
ELTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Robert Connelly since 9/11/2023

Holdings reported by Robert Connelly for Elicio Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 47K $273K $5.81 Jun 1, 2023 Direct
Stock Option (right to buy) 225K Feb 1, 2024 Direct Common Stock

Transactions reported by Robert Connelly for Elicio Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.